88 related articles for article (PubMed ID: 5106461)
21. Serum lactate dehydrogenase isoenzyme changes in carcinoma of the prostate.
Belitsky P; Elhilali MM; Oliver JA; MacKinnon KJ
J Urol; 1970 Jun; 103(6):770-3. PubMed ID: 4192349
[No Abstract] [Full Text] [Related]
22. [Prostatic cancer: indications for hormone therapy].
Bruntsch U; Gallmeier WM
MMW Munch Med Wochenschr; 1979 Mar; 121(9):300-2. PubMed ID: 85258
[No Abstract] [Full Text] [Related]
23. Preliminary report on the effect of gestonorone capronate on human prostate LDH-isoenzymes.
Govaerts J; van Sande M; Van Camp K
Acta Urol Belg; 1978; 46(4):389-92. PubMed ID: 83788
[No Abstract] [Full Text] [Related]
24. Lactate dehydrogenase isoenzymes in human prostatic fluid: an aid in recognition of malignancy?
Grayhack JT; Wendel EF; Lee C; Oliver L; Cohen E
J Urol; 1977 Jul; 118(1 Pt 2):204-8. PubMed ID: 69042
[TBL] [Abstract][Full Text] [Related]
25. Flutamide plus castration in patients with previously untreated prostate cancer.
Labrie F
Urology; 1997 Sep; 50(3):479. PubMed ID: 9301724
[No Abstract] [Full Text] [Related]
26. New screening and diagnostic tests for prostate cancer and immunologic assessment.
Catalona WJ; Menon M
Urology; 1981 Mar; 17(Suppl 3):61-5. PubMed ID: 6163244
[No Abstract] [Full Text] [Related]
27. Lactate dehydrogenase isoenzymes in hyperplasia and carcinoma of the prostate: a clinical study.
Elhilali MM; Oliver JA; Sherwin AL; Mackinnon KJ
J Urol; 1967 Dec; 98(6):686-92. PubMed ID: 4169732
[No Abstract] [Full Text] [Related]
28. [Aspects for hormone therapy in prostate cancer].
Gorski J; Böhm WD; Kelly LU
Z Urol Nephrol; 1981 Sep; 74(9):635-41. PubMed ID: 7314984
[TBL] [Abstract][Full Text] [Related]
29. The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage.
Meid FH; Gygi CM; Leisinger HJ; Bosman FT; Benhattar J
J Urol; 2001 May; 165(5):1802-5. PubMed ID: 11342979
[TBL] [Abstract][Full Text] [Related]
30. Antiandrogen monotherapy for prostate cancer.
Wirth MP; Hakenberg OW
Curr Probl Cancer; 2003; 27(1):45-8. PubMed ID: 12569350
[No Abstract] [Full Text] [Related]
31. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
Sharief FS; Mohler JL; Sharief Y; Li SS
Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
[TBL] [Abstract][Full Text] [Related]
32. Lactate dehydrogenase is a prognostic indicator for prostate cancer patients with bone metastasis.
Naruse K; Yamada Y; Aoki S; Taki T; Nakamura K; Tobiume M; Zennami K; Katsuda R; Sai S; Nishio Y; Inoue Y; Noguchi H; Hondai N
Hinyokika Kiyo; 2007 May; 53(5):287-92. PubMed ID: 17561711
[TBL] [Abstract][Full Text] [Related]
33. [Statistical study of the percentages of serum lactic dehydrogenase isoenzymes in normal subjects and cancer patients].
Garbe E; Randoux A; Vieillard A; Borel JP; Cattan A
Rev Eur Etud Clin Biol; 1971 May; 16(5):482-4. PubMed ID: 5113311
[No Abstract] [Full Text] [Related]
34. [The effect of the prostatic massage on the activity of acid serum phosphatase in prostatic carcinoma].
Ziesche HW
Z Urol Nephrol; 1967 Aug; 60(8):529-34. PubMed ID: 5586587
[No Abstract] [Full Text] [Related]
35. Hormonal therapy of prostate cancer.
Labrie F
Prog Brain Res; 2010; 182():321-41. PubMed ID: 20541672
[TBL] [Abstract][Full Text] [Related]
36. [New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
Labrie F; Dupont A; Belanger A; Lefebvre FA; Raynaud JP
J Pharmacol; 1983; 14 Suppl 3():117-35. PubMed ID: 6423907
[TBL] [Abstract][Full Text] [Related]
37. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy.
Morote J; Orsola A; Planas J; Trilla E; Raventós CX; Cecchini L; Catalán R
J Urol; 2007 Oct; 178(4 Pt 1):1290-5. PubMed ID: 17698136
[TBL] [Abstract][Full Text] [Related]
38. Cytology of metastatic prostate cancer following orchiectomy and antiandrogen therapy: a diagnostic challenge.
Rapkiewicz A; Gorokhovsky R; Farcon E; Das K
Diagn Cytopathol; 2008 Jul; 36(7):499-502. PubMed ID: 18528888
[TBL] [Abstract][Full Text] [Related]
39. Castration-resistant prostate cancer: descriptive yet pejorative?
Crawford ED; Petrylak D
J Clin Oncol; 2010 Aug; 28(23):e408. PubMed ID: 20547989
[No Abstract] [Full Text] [Related]
40. [Serum aldolase in prostatic cancer].
Maganto-Pavón E; Isorna S; Navajo-Galindo JA; Daimiel-Fernández ER; Martínez-Piñeiro JA
Actas Urol Esp; 1979; 3(4):227-30. PubMed ID: 484308
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
